Literature DB >> 17544871

A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis.

Phillip Fleshner1, Andrew Ippoliti, Marla Dubinsky, Steven Ognibene, Eric Vasiliauskas, Marjorie Chelly, Ling Mei, Konstantinos A Papadakis, Carol Landers, Stephan Targan.   

Abstract

BACKGROUND & AIMS: Although acute pouchitis (AP) after ileal pouch-anal anastomosis (IPAA) for UC is common and easily treated, chronic pouchitis (CP) remains a difficult management issue. The aim of this study was to identify important clinical risk factors associated with AP or CP.
METHODS: AP and CP were prospectively assessed, and demographic, disease, and treatment characteristics were tabulated. Univariate and multivariate analyses were performed to evaluate associations between AP or CP and potential risk factors.
RESULTS: Two hundred IPAA patients were followed for a median of 24 months (range, 3-117 months). Thirty-six patients (18%) developed AP, and 23 patients (12%) developed CP. On univariate analysis, the use of steroids before colectomy and smoking were associated with the development of AP. CP was associated with male gender, smoking, length of follow-up, extraintestinal manifestations, backwash ileitis, and elevated (450x10(9)/L) platelet count. On multivariate analysis, the following risk factors were found to be independently associated with AP: use of steroids before colectomy (odds ratio [OR], 3.7; 95% confidence interval [CI], 1.5-8.9; P = .004) and smoking (OR, 2.3; 95% CI, 1.1-5.3; P = .04). CP was directly associated with extraintestinal manifestations (OR, 3.5; 95% CI, 1.1-11.1; P = .03), elevated platelet count (OR, 3.1; 95% CI, 1.1-8.9; P = .03), and increased length of follow-up (OR, 1.3; 95% CI, 1.1-1.6; P = .002). Smoking reduced the incidence of CP (OR, 0.2; 95% CI, 0.05-0.74; P = .04).
CONCLUSIONS: Clinical factors associated with AP included use of steroids before colectomy and smoking. Factors directly related to CP were extraintestinal manifestations, elevated platelet count, and length of follow-up after IPAA. Smoking appears to protect against the development of CP.

Entities:  

Mesh:

Year:  2007        PMID: 17544871     DOI: 10.1016/j.cgh.2007.03.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  19 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.

Authors:  Orlaith B Kelly; Morgan Rosenberg; Andrea D Tyler; Joanne M Stempak; A Hillary Steinhart; Zane Cohen; Gordon R Greenberg; Mark S Silverberg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

3.  Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis.

Authors:  Hans H Wasmuth; Gerd Tranø; Birger H Endreseth; Arne Wibe; Astrid Rydning; Helge E Myrvold
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

Review 4.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Diagnosis and management of postoperative ileal pouch disorders.

Authors:  Bo Shen
Journal:  Clin Colon Rectal Surg       Date:  2010-12

Review 6.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

7.  Quality of life, continence and frequency of pouchitis following laparoscopic versus open colectomy and ileal pouch-anal anastomosis: an Irish perspective.

Authors:  C Browne; F Shaikh; N Iqbal; B McGovern; S Rowe; P Neary
Journal:  Ir J Med Sci       Date:  2014-11-25       Impact factor: 1.568

8.  FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis.

Authors:  Toshimitsu Araki; Mikio Kawamura; Koji Tanaka; Yoshiki Okita; Hiroyuki Fujikawa; Keiichi Uchida; Yuji Toiyama; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

9.  A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis.

Authors:  Evan White; Gil Y Melmed; Eric A Vasiliauskas; Marla Dubinsky; Dror Berel; Stephan R Targan; Phillip R Fleshner
Journal:  Dis Colon Rectum       Date:  2010-07       Impact factor: 4.585

10.  Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus.

Authors:  Xian-Rui Wu; Jean Ashburn; Feza H Remzi; Yi Li; Hagar Fass; Bo Shen
Journal:  J Gastrointest Surg       Date:  2015-10-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.